Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating chronic rhinitis

A technology for sinusitis and chronic rhinitis, applied in the field of compound traditional Chinese medicine oral tablets, can solve problems such as mental inattention, memory and academic performance decline, and low work efficiency.

Inactive Publication Date: 2013-03-20
SHANGHAI PUDONG GAOXING BIOTECH RES INST
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In terms of work and study: rhinitis causes headaches for adults, unconsciousness, drowsiness, and low work efficiency; while adolescents suffer from nasal congestion, headaches and other symptoms caused by rhinitis, resulting in inattention, memory and academic performance.
The current commercially available drugs for the treatment of rhinitis are obviously less effective, and some rely on hormone antibiotics, which produce many side effects, which are extremely unfavorable to the growth and development of teenagers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for treating chronic rhinitis
  • Medicament for treating chronic rhinitis
  • Medicament for treating chronic rhinitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] The present invention is used in more than 20 cases of patients with chronic rhinitis, acute rhinitis, allergic rhinitis, and sinusitis, taking 1.5-2 grams of tablets or capsules orally each time, three times a day, swallowing them with warm water after meals, and taking one to three times a day For two weeks, at the same time, add 30% goose grazing, 30% cocklebur, 30% angelica, 10% peppermint (ground and stirred evenly, powdered and sealed in a bottle) to stuff the nose with cotton wool, 0.5 grams per nostril , one to two times a day. After three or four days, the nasal congestion improved, the runny nose decreased, the headache was significantly relieved, and the breathing was smooth. Except for one case of turbinate hypertrophy, who went to the ENT specialist hospital to remove the nasal polyps, the effect of the other cases was remarkable, and the quality of life was significantly improved.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a compound traditional Chinese medicament oral tablet, in particular to a traditional Chinese medicament compound preparation for treating acute rhinitis, chronic rhinitis, allergic rhinitis, sinusitis and the like. The medicament for treating chronic rhinitis is an oral tablet or capsule prepared from radix scutellariae, fineleaf schizonepeta herb, flos magnoliae liliflorae, divaricate saposhnikovia root, angelica dahurica, herba siegesbeckiae, manchurian wild ginger, atractylodes lancea, mint, astragalosides, wrinkled gianthyssop herb and pulvis fellis suis, and has an obvious effect on treating acute rhinitis, chronic rhinitis, allergic rhinitis, sinusitis and the like. The medicament for treating chronic rhinitis comprises the following main components in weight percentage: 20% of radix scutellariae, 10% of fineleaf schizonepeta herb, 10% of flos magnoliae liliflorae, 10% of divaricate saposhnikovia root, 10% of angelica dahurica, 10% of herba siegesbeckiae, 5% of manchurian wild ginger, 5% of atractylodes lancea, 5% of mint, 5% of astragalosides, 5% of wrinkled gianthyssop herb and 5% of pulvis fellis suis. The twelve drugs are ground in proportion and stirred uniformly to prepare a tablet or a capsule. 1.5 to 2 g of the medicament is orally taken with warm water after a meal each time and is taken for three times a day continuously for one or two weeks; and meanwhile, 30% of centipeda minima, 30% of siberian cocklour fruit, 30% of angelica dahurica and 10% of mint are ground and stirred into uniform powder and then bottled hermetically; and the powder is wrapped with a cotton to be stuffed in a nose, and 0.5 g of the powder is used for each nose for one to two times a day.

Description

1. Technical field: [0001] The invention relates to a compound traditional Chinese medicine oral tablet, more specifically a traditional Chinese medicine compound preparation for treating acute and chronic rhinitis, allergic rhinitis, sinusitis, allergic rhinitis and the like. 2. Background technology: [0002] Rhinitis refers to inflammation of the nasal mucosa and submucosal tissues. Patients often have symptoms such as nasal congestion, runny nose, nasal itching, throat discomfort, and coughing. Rhinitis can be divided into several types such as acute, chronic, atrophic, and allergic. Rhinitis persists for a long time and deteriorates, which is closely related to life. In terms of work and study: rhinitis causes headaches for adults, confusion, drowsiness, and low work efficiency; while adolescents suffer from nasal congestion, headaches and other symptoms caused by rhinitis, resulting in inattention, memory and academic performance. Significant decline. Currently comm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/575A61K9/20A61K9/48A61P11/02A61K35/413
Inventor 夏伟荣胡宝山陆培群
Owner SHANGHAI PUDONG GAOXING BIOTECH RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products